ArticleHealth information science and systems2020
Bio-inspired dimensionality reduction for Parkinson's disease (PD) classification.
Article in Health information science and systems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Hybrid feature selection with novel deep learning model for COVID-19 risk prediction.Scientific reports · 2026Article
- DualGCN-GE: integration of spatiotemporal representations from whole-blood expression data with dual-view graph convolution network to identify Parkinson's disease subtypes.BMC bioinformatics · 2025Article
- Article
- Article
- Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review.Health information science and systems · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the demand for developing the efficient Machine Learning (ML) classification models for healthcare data, and the potentiality of Bio-Inspired Optimization (BIO) algorithms to tackle the problem of high dimensional data, we investigate the range of ML classification models trained with the optimal subset of features of PD data set for efficient PD classification. We used two BIO algorithms, Genetic Algorithm (GA) and Binary Particle Swarm Optimization (BPSO), to determine the optimal subset of features of PD data set. The data set chosen for investigation comprises 756 observations (rows or records) taken over 755 attributes (columns or dimensions or features) from 252 PD patients. We employed MaxAbsolute feature scaling method to normalize the data and one hold cross-validation method to avoid biased results. Accordingly, the data is split in to training and testing set in the ratio of 70% and 30%. Subsequently, we employed GA and BPSO algorithms separately on 11 ML classifiers (Logistic Regression (LR), linear Support Vector Machine (lSVM), radial basis function Support Vector Machine (rSVM), Gaussian Naïve Bayes (GNB), Gaussian Process Classifier (GPC), k-Nearest Neighbor (kNN), Decision Tree (DT), Random Forest (RF), Multilayer Perceptron (MLP), Ada Boost (AB) and Quadratic Discriminant Analysis (QDA)), to determine the optimal subset of features (reduction of dimensionality) contributing to the highest classification accuracy. Among all the bio-inspired ML classifiers employed: GA-inspired MLP produced the maximum dimensionality reduction of 52.32% by selecting only 359 features and delivering 85.1% of the classification accuracy; GA-inspired AB delivered the maximum classification accuracy of 90.7% producing the dimensionality reduction of 41.43% by selecting only 441 features; And, BPSO-inspired GNB produced the maximum dimensionality reduction of 47.14% by selecting 396 features and delivering the classification accuracy of 79.3%; BPSOMLP delivered the maximum classification accuracy of 89% and produced 46.48% of the dimensionality reduction by selecting only 403 features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.